India’s Generics-Only Rx Rule: Not What The Doctor Ordered Or What Pharma Wants?

New norms call for generics-only prescriptions and prohibits doctors from engaging in third-party educational activity backed by pharma in India. Will pharma need to rethink its branded generics strategy in India or is a tempering/deferment of the norms on the cards?